Scott Kathleen D. Insider Trades

Insider Trading History

Track insider trading activity for Scott Kathleen D.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Dermata Therapeutics- Warrants (13/08/2026)
Dermata Therapeutics- Warrants (13/08/2026) DRMAW
Director
Holding Value $34.3 2,500 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.3 2,500 shares
$0.02
$0.01
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Financial Officer
Holding Value $2.18M 240,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.76M 240,000 shares
$11.49
$9.07
Dermata Therapeutics
Dermata Therapeutics DRMA
Director
Holding Value $3.13k 2,500 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.45k 2,500 shares
$2.18
$1.25
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Financial Officer
Holding Value $6.71M 739,830 shares
Last Trade
Aug 21, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$186k 12,500 shares
$14.87
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Financial Officer
Holding Value $204k 22,542 shares
Last Trade
Aug 21, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$186k 12,500 shares
$14.87
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Financial Officer
Holding Value $91.1k 10,042 shares
Last Trade
Aug 21, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$188k 12,500 shares
$15.00
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Financial Officer
Holding Value $521k 57,424 shares
Last Trade
May 20, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$717k 50,000 shares
$14.33
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Financial Officer
Holding Value $6.82M 752,330 shares
Last Trade
May 20, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$717k 50,000 shares
$14.33
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Financial Officer
Holding Value $67.3k 7,424 shares
Last Trade
May 20, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$705k 50,000 shares
$14.10
$9.07
Dermata Therapeutics
Dermata Therapeutics DRMA
Director
Holding Value $6.25k 5,000 shares
Last Trade
Jan 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.9k 5,000 shares
$1.38
$1.25
Dermata Therapeutics- Warrants (13/08/2026)
Dermata Therapeutics- Warrants (13/08/2026) DRMAW
Director
Holding Value $68.5 5,000 shares
Last Trade
Jan 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$87 5,000 shares
$0.02
$0.01
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Financial Officer
Holding Value $1.6M 176,700 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.89M 176,700 shares
$10.71
$9.07
NKGen Biotech- Warrants (01/09/2028)
NKGen Biotech- Warrants (01/09/2028) NKGNW
Director
Holding Value $15.1k 500,000 shares
Last Trade
Dec 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.7k 800,000 shares
$0.04
$0.03
NKGen Biotech
NKGen Biotech NKGN
Director
Holding Value $30k 500,000 shares
Last Trade
Dec 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$351k 800,000 shares
$0.44
$0.06
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Financial Officer
Holding Value $7.28M 802,330 shares
Last Trade
Oct 16, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$207k 12,500 shares
$16.52
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Financial Officer
Holding Value $44.9k 4,949 shares
Last Trade
Oct 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$200k 12,500 shares
$16.00
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Financial Officer
Holding Value $158k 17,449 shares
Last Trade
Oct 16, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$207k 12,500 shares
$16.52
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Financial Officer
Holding Value $7.39M 814,830 shares
Last Trade
Aug 20, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$186k 12,500 shares
$14.89
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Financial Officer
Holding Value $120k 13,199 shares
Last Trade
Aug 20, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$200k 12,500 shares
$16.00
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Financial Officer
Holding Value $233k 25,699 shares
Last Trade
Aug 20, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$186k 12,500 shares
$14.89
$9.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up